Medical devices tenders in Germany.

The national procurement portal shows around 160 medical devices tenders in the last 120 days, up 113% from the prior period. Activity is running at about 40 a month and around 9 a week, so the flow is active rather than sporadic.

The value profile is highly skewed. The average announced value is EUR 485K, but the median is only EUR 1K, and total announced value is EUR 18.9M. That means a few material opportunities sit alongside many low value or placeholder style notices.

There are around 110 active buying organisations, but concentration is high. The top five buyers account for 77% of disclosed value, so a supplier does not need broad coverage to matter. Key names include DAK Gesundheit, Universitätsklinikum Münster, AOK PLUS, BARMER, and Landkreis Mecklenburgische Seenplatte.

Timing depends on the specific notice, because the portal includes both substantial tenders and low value postings. The safe approach is to check each notice immediately on publication and confirm deadlines, documents, and scope before deciding whether to bid.

Yes. The market is published on Germany’s national procurement portal, so suppliers outside Germany can review and compete if they meet the notice requirements. As always, eligibility depends on the specific tender documents, technical scope, and administrative conditions in each case.

Yes. The market looks newcomer friendly: 84% of winners took exactly one contract, and there are around 51 winning companies overall. That pattern suggests that new entrants can win without needing a long local track record, especially when they target the right buyers.

They are published on Germany’s national procurement portal in CPV division 33 for medical devices. If you search that portal consistently, you will see the full flow of announced opportunities, including both the high value tenders and the long tail of small notices.

Competition is uneven. The buyer side is concentrated, while the winner side is relatively open, with around 51 winning companies and 84% of winners taking exactly one contract. That means the market rewards focus and timing more than broad coverage.

Focus on the few value heavy buyers rather than the full tender flow. Prioritize organisations that already account for most disclosed value, then screen notices for medical device relevance, buyer fit, and realistic contract size. That is usually more useful than chasing every posting.

Otnox helps suppliers focus on the notices that matter most. In a market with many low value postings and a small number of high value buyers, Otnox can support targeted monitoring, buyer prioritisation, and faster identification of the best fit opportunities.